-
-
-
-
-
-
-
Alexion Pharma (ALXN) Announces Upcoming Data Presentations at the 26th European Hematology Association Virtual Congress
-
-
-
-
-
-
-
Alexion to Report First Quarter 2021 Results on Monday, May 3, 2021
-
-
-
-
-
-
-
BioMarin Pharma (BMRN) Ticks Higher for Second Day as It is Seen as Next Target in Sector
-
-
-
-
-
-
-
Alexion Highlights Promising Pipeline & Distinguished Rare Disease Capabilities at Virtual Investor Day
-
-
-
-
-
-
-
Alexion Completes Acquisition of Portola
-
-
-
-
-
-
-
Portola Pharmaceuticals Reports First Quarter 2020 Financial Results and Provides Corporate Update
-
-
-
-
-
-
-
Alexion Receives CHMP Positive Opinion for ULTOMIRIS® (ravulizumab) in Atypical Hemolytic Uremic Syndrome (aHUS)
-
923,823 total articles have been posted to this entity.
Click Here to Sign-Up for StreetInsider.com Premium to View All